Author

Radoslav Mangaldzhiev

Observed name: Mangaldzhiev, Radoslav

Institution: Specialised Hospital for Active Treatment of Oncology

Observed institutions: Queen Giovanna Hospital, Medical University of Sofia, Specialised Hospital for Active Treatment of Oncology

ORCID: 0000-0002-1109-6808

Observed ORCID: 0000-0002-1109-6808

OpenAlex ID: A5073186905

Contemporary Molecular Markers for Predicting Systemic Treatment Response in Urothelial Bladder Cancer: A Narrative Review

2024 · George Dimitrov, Radoslav Mangaldzhiev, et al. · Cancers · 12

Precision Medicine in Castration-Resistant Prostate Cancer: Advances, Challenges, and the Landscape of PARPi Therapy—A Narrative Review

2024 · George Dimitrov, Radoslav Mangaldzhiev, et al. · International Journal of Molecular Sciences · 7

Adequate effectiveness of ribociclib plus letrozole or fulvestrant in patients with advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated in routine Bulgarian clinical practice

2023 · Manoela Manova, Jeliazko Arabadjiev, et al. · Biotechnology & Biotechnological Equipment · 2

Real-world evidence of first-line osimertinib effectiveness in Bulgarian patients: a retrospective analysis

2025 · Manoela Manova, Boryana Ivanova, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 1

Real-world effectiveness of dabrafenib and trametinib in patients with BRAF-positive melanoma treated in routine Bulgarian clinical practice

2024 · Alexandra Savova, Boryana Ivanova, et al. · Pharmacia · 1

Role of nuclear medicine SPECTCT methods in the diagnosis of Urinary Tract Urothelial Cell Cancer

2021 · Sonya Sergieva, Albena Fakirova, et al. · Journal of Endourology and Minimally Invasive Surgery

Clinical Application of SPECT-CT Imaging with 99mTc-PSMA in Patients with Recurrent Prostate Cancer

2021 · Sonya Sergieva, Radoslav Mangaldzhiev, et al. · Journal of Endourology and Minimally Invasive Surgery

Works count: 8

Citation count: 23

H-index: 2

I10-index: 1